At the same time, transplantation of merely 200–500 KRAS intact cells resulted in the formation of primary and metastatic tumors with a median animal survival of three weeks, whereas none of the KRAS KO cell lines were capable of developing tumors under these conditions after 3 months. The gene discussed is KRAS; the disease is metastatic neoplasm.